Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced vasculitis.

Marta Lucia Cuellar1

  • 1Section of Allergy, Immunology and Rheumatology, Department of Medicine, Tulane University Medical Center, 1700 Perdido Street-SL57, New Orleans, LA, 70112-2822, USA. mcuellar@tulane.edu

Current Rheumatology Reports
|January 19, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Type I Interferonopathies: Fifteen Years On, From Concept to Therapeutic Perspectives.

Current rheumatology reports·2026
Same journal

Intensive Care Management of ANCA-associated Vasculitides: a Narrative Review.

Current rheumatology reports·2026
Same journal

The Role of Musculoskeletal Ultrasound in Psoriatic Arthritis: From Preclinical Detection to Treatment Monitoring.

Current rheumatology reports·2026
Same journal

Correction to: Is Gout and Autoinflammatory Disease?

Current rheumatology reports·2026
Same journal

Risks and Management of Glucocorticoid Therapy for Patients with Rheumatic Disease Having Surgery.

Current rheumatology reports·2026
Same journal

Perioperative Management Considerations for Patients with Systemic Lupus Erythematosus.

Current rheumatology reports·2026
See all related articles

Certain medications can trigger various forms of vasculitis, a condition affecting blood vessels. Identifying and stopping the causative drug often leads to rapid improvement in drug-induced vasculitis.

Area of Science:

  • Immunology
  • Rheumatology
  • Pharmacology

Background:

  • Therapeutic agents, including biologic response modifiers, can induce diverse vasculitic manifestations.
  • These include hypersensitivity vasculitis, leukocytoclastic vasculitis, and specific syndromes like Wegener's granulomatosis.
  • Pathogenic mechanisms are multifactorial, involving cell-mediated and humoral immune responses.

Purpose of the Study:

  • To review the spectrum of vasculitic manifestations induced by therapeutic agents.
  • To highlight the importance of identifying causative drugs in drug-induced vasculitis.
  • To discuss the clinical presentation, serologic, and pathologic findings in relation to idiopathic vasculitis.

Main Methods:

  • Literature review of drug-induced vasculitis.

Related Experiment Videos

  • Analysis of clinical presentations and outcomes.
  • Comparison of drug-induced and idiopathic vasculitis.

    • Main Results:

    • Drug-induced vasculitis presents similarly to idiopathic forms in clinical, serologic, and pathologic findings.
    • Discontinuation of the offending drug frequently results in rapid improvement.
    • Severity ranges from mild to fatal, with variable disease courses.

    Conclusions:

    • Therapeutic agents are an important cause of vasculitis.
    • Prompt identification and withdrawal of the causative agent are crucial for effective management.
    • Understanding the role of immune mechanisms is key to further research.